Healthgrades Recognizes MetroWest Medical Center for Pulmonary Award
Apr 12, 2024Nationally-Recognized for Treatment of Pulmonary Embolism--Five Star Recipient 2024
MetroWest Medical Center CEO John Whitlock, Jr., accepts the award from Alicia Dreyer, Senior Director of Quality Solutions for Healthgrades.
FRAMINGHAM, Mass. – MetroWest Medical Center announced today it has achieved a five-star rating for Treatment of Pulmonary Embolism, according to new research released by Healthgrades, a leading resource consumers use to find a hospital or doctor. This achievement reflects MetroWest Medical Center’s commitment to consistently delivering the best care possible and places the organization in the upper echelon of hospitals for treatment of pulmonary embolism nationwide.
“At MetroWest Medical Center, we are very proud of our organization’s commitment to high-quality specialty care,” says John Whitlock, Chief Executive Officer of MetroWest Medical Center. “It’s a special designation to be nationally-recognized for treatment of pulmonary embolism. This award is a testament to the incredible work that our caregivers do every day to ensure safe, high-quality care and an outstanding experience for our patients we are privileged to serve.”
Healthgrades evaluates hospitals solely on clinical outcomes: risk-adjusted mortality and complications. By focusing on what matters most–patient outcomes–Healthgrades ratings provide critical feedback for both patients and hospitals. By offering easy access to objective performance measures, Healthgrades gives consumers the information they need to find a hospital that excels in providing the care they need. And, by shining a light on strengths and weaknesses, Healthgrades ratings help direct hospitals to opportunities for clinical improvement. The 2024 hospital assessment evaluated patient mortality and complication rates for 35 common conditions and procedures at approximately 4,500 hospitals nationwide to identify the top performers.
MetroWest Medical Center leadership display their Healthgrades award as a five-star recipient in the Treatment of Pulmonary Embolism.
The 2024 Healthgrades analysis revealed that the variation in performance between five-star and one-star hospitals continues to widen, making it increasingly important to seek care at top-rated programs. From 2020 through 2022, if all hospitals as a group performed similarly to five-star hospitals, on average, 215,667 lives could potentially have been saved, and 149,521 patients could have avoided potential complications.*
“Healthgrades congratulates MetroWest Medical Center for being a national leader in treatment of pulmonary embolism and demonstrating a deep commitment to providing high-quality care to all patients,” said Brad Bowman, MD, Chief Medical Officer and Head of Data Science at Healthgrades. “As health systems nationwide endeavor to elevate their quality of care, these elite facilities provide a roadmap for success. We commend MetroWest Medical Center for their dedication to excellence in patient care.”
Consumers can visit Healthgrades.com to learn more about how Healthgrades measures hospital quality and access a patient-friendly overview of how we rate and why hospital quality matters here.
*Statistics are based on Healthgrades analysis of MedPAR data for 2020 through 2022 and represent three-year estimates for Medicare patients only. Click here to view the complete 2024 Specialty Excellence Awards and Ratings Methodology.